OceanTech Acquisitions I Corp. (OTEC) to Combine with Captura Biopharma

OceanTech Acquisitions I Corp. (OTEC) to Combine with Captura Biopharma

OceanTech I (NASDAQ:OTEC) has entered into a definitive agreement to combine with drug developer Captura Biopharma for a post-transaction equity value of $224.3 million. Little Rock, Arkansas-based Captura is developing treatments for radiation and other heavy-metal poisonings. The combined company is expected to trade on the Nasdaq once the deal is completed in the fourth
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.